Kathleen Mullane to Urokinase-Type Plasminogen Activator
This is a "connection" page, showing publications Kathleen Mullane has written about Urokinase-Type Plasminogen Activator.
Connection Strength
0.060
-
Recombinant urokinase for restoration of patency in occluded central venous access devices. A double-blind, placebo-controlled trial. Thromb Haemost. 2004 Sep; 92(3):575-82.
Score: 0.060
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.